Brief: Cannara Biotech Delivers Q4
24/11/2025 12:22
Nov 24 (Reuters) - Cannara Biotech Inc LOVE.V: CANNARA BIOTECH DELIVERS RECORD FISCAL 2025 REVENUE AND PROFITABILITY, ACHIEVES FIRST YEAR OF POSITIVE RETAINED EARNINGS CANNARA BIOTECH Q4 EPS CAD 0.04 CANNARA BIOTECH Q4 REVENUE CAD 28.3 MILLION CANNARA BIOTECH Q4 NET INCOME CAD 3.3 MILLION Source text: ID:nGNX9c2MKC Further company coverage: LOVE.V ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cannara Biotech
See all newsCanada Research Roundup: Cannara Biotech ,Equinox Gold , Winpak
Brief: Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced At C$2.10 Per Common Share
Brief: Cannara Biotech Delivers Q4
Cannabis firm Cannara Biotech's Q4 revenue rises on market expansion
Brief: Cannara Biotech Q4 EPS CAD 0.04